Holen Sie sich die Stockscreener-App
4.13
6.17%
0.24
Handel nachbörslich:
4.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
MNKD|MannKind Corp|Price:4.130|Chg%:+0.240 - TradingKey
MannKind (MNKD) Stock Looks Undervalued On Cash Flow Yet Mixed On Broader Checks - Yahoo Finance
MannKind Corporation (MNKD) Shares Surge on FDA Approval and $50M Placement - GuruFocus
MannKind Corporation Raises $50 Million in Private Placement Following FDA Approval of Furoscix ReadyFlow - Kalkine Media
MannKind closes $50M financing, wins FDA nod for Furoscix auto-injector - MassDevice
MannKind Corporation (MNKD) stock price, news, quote and history - Yahoo Finance UK
MannKind Announces FDA Approval of Furoscix ReadyFlow, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease - FinanzNachrichten.de
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease - Benzinga
MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost - Yahoo Finance
MannKind Stock Jumps After FDA Clears Furoscix Auto-Injector, Firm Secures $50 Million PIPE - finance.biggo.com
MannKind Corporation (MNKD) Stock Price, News, Quote & History - Yahoo! Finance Canada
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure - Pharmacy Times
H.C. Wainwright reiterates Buy on MannKind stock ahead of PDUFA - Investing.com
MannKind shares surge after FDA approves Furoscix ReadyFlow and company secures $50 million financing - Yahoo Finance
H.C. Wainwright reiterates Buy on MannKind stock ahead of PDUFA By Investing.com - Investing.com Canada
MNKD Stock Rises Premarket As FDA Verdict Nears – Retail Optimism Builds - Stocktwits
Why is MannKind stock rallying today? - Investing.com
MannKind raises $50 million in private placement led by Frazier - Investing.com
MannKind stock jumps 6% on FDA approval, $50M financing - Investing.com
At-home autoinjector delivers IV-equivalent therapy in under 10 seconds - Stock Titan
MannKind (MNKD) Set for Potential Growth Ahead of FDA Decision - GuruFocus
MNKD Stock Heads For Strongest Month In Over Three Years As FDA Catalyst Draws Closer - Stocktwits
MNKD Stock Jumps On Receiving FDA Approval For Afrezza To Treat Diabetes In Children - Stocktwits
Form 4 MannKind Corp For: 21 July By Investing.com - Investing.com South Africa
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
MannKind EVP David Thomson sells $97,641 in MNKD shares on July 17 - Investing.com India
Form 4 MannKind Corp For: 21 July - Investing.com India
MNKD Stock Price, Quote & Chart - ChartMill
MannKind Executive Sells 123,000 Shares Amid Performance Concerns - Intellectia AI
What This MannKind Filing Reveals About Three Years of Underperformance - Yahoo Finance
What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million - Yahoo Finance
Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk - Yahoo Finance
Form 4 MannKind Corp For: 20 July By Investing.com - Investing.com Nigeria
MannKind CEO Sells Shares to Cover Tax Liabilities - Intellectia AI
Is MannKind a Stock to Sell After Its CEO Let Go of 363,200 Shares? - Yahoo Finance
MannKind EVP David Thomson sells $97,641 in company stock - Investing.com UK
MannKind director Steven Binder sells $213,089 in company stock By Investing.com - Investing.com India
MannKind EVP David Thomson sells $97,641 in company stock By Investing.com - Investing.com South Africa
Form 4 MannKind Corp For: 17 July By Investing.com - Investing.com South Africa
MannKind Corp (MNKD) EVP receives 70,550 shares from performance RSUs - Stock Titan
MannKind (MNKD) CEO vests 350,260 shares, withholds stock for taxes - Stock Titan
MannKind director Steven Binder sells $213,089 in company stock - Investing.com
MannKind (MNKD) insider schedules 24,109-share sale and reports new RSU, PSU awards - Stock Titan
Planned sale of 52,485 MNKD shares disclosed by MNKD (NASDAQ: MNKD) - Stock Titan
MannKind Corporation (MNKD) Up 20% Since Afrezza FDA Approval - Yahoo Finance
0.46%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):